Multicentre Retrospective Study to Understand Anti-thrombotic Treatment Patterns and Outcomes of Acute Coronary Syndrome (ACS) Patients
NCT ID: NCT01280630
Last Updated: 2012-02-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
500 participants
OBSERVATIONAL
2011-02-28
2011-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This retrospective study is designed to provide a rapid and quick analysis of the existing database of ACS patients. So as to ensure quality check in the study, a pilot study will be conducted with around 500 patients at 10 centres across India and based on the meaningful results of the pilot study, full retrospective multi-centric study will be initiated at various selected centres across India. This study will use available registry data from a defined time period of Jan 2007-Dec 2009.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Intracoronary Autologous Stem Cell Transplantation in ST Elevation Myocardial Infarction: TRACIA STUDY.
NCT00725738
PRediction of Acute Coronary Syndrome in Acute Ischemic StrokE
NCT03609385
Assessment of Thrombogenicity in Acute Coronary Syndrome
NCT00728286
Study Evaluating How Patients With Acute Coronary Syndrome Are Managed During 2 Years After Discharge
NCT01171404
Comparison of Two Treatment Strategies in Patients With an Acute Coronary Syndrome Without ST Elevation
NCT00445263
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of STEMI, NSTEMI or UA using Standard and Universal Definition of Myocardial Infarction
Exclusion Criteria
* UA, STEMI and NSTEMI occurring in patients already hospitalized for other reasons
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Paurus M Irani, MD
Role: STUDY_DIRECTOR
AZ India
Dr Jamshed Dalal
Role: PRINCIPAL_INVESTIGATOR
Kokila Ben Dhirubhai Ambani Hospital
Dr Keyur Parikh
Role: PRINCIPAL_INVESTIGATOR
Heart Care Hospitals
Dr S S Ramesh
Role: PRINCIPAL_INVESTIGATOR
Bhagwan Mahaveer Jain Hear Centre
Dr Upendra Kaul
Role: PRINCIPAL_INVESTIGATOR
Escorts Hospitals
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Hyderabad, Andhra Pradesh, India
Research Site
Ahmedabad, Gujarat, India
Research Site
Bangalore, Karnataka, India
Research Site
Mumbai, Maharashtra, India
Research Site
Pune, Maharashtra, India
Research Site
New Delhi, National Capital Territory of Delhi, India
Research Site
Chennai, Tamil Nadu, India
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIS-CIN-XXX-2010/1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.